Designing Adverse Event Forms for Real-World Reporting: Participatory Research in Uganda

The wide-scale roll-out of artemisinin combination therapies (ACTs) for the treatment of malaria should be accompanied by continued surveillance of their safety. Post-marketing pharmacovigilance (PV) relies on adverse event (AE) reporting by clinicians, but as a large proportion of treatments are pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Emma C., Chandler, Clare I. R., Innocent, Simeon H. S., Kalumuna, Charles, Terlouw, Dianne J., Lalloo, David G., Staedke, Sarah G., Haaland, Ane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315549/
https://www.ncbi.nlm.nih.gov/pubmed/22479335
http://dx.doi.org/10.1371/journal.pone.0032704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315549/
https://www.ncbi.nlm.nih.gov/pubmed/22479335
http://dx.doi.org/10.1371/journal.pone.0032704

Ejemplares similares